Evidence map›Paper›PMID 19916165›Full record

ArticleProtein science : a publication of the Protein Society2010

The importance of valine 114 in ligand binding in beta(2)-adrenergic receptor.

Makoto Arakawa, Naveena Yanamala, Jasbir Upadhyaya, Andrew Halayko, Judith Klein-Seetharaman, Prashen Chelikani

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Makoto ArakawaDepartment of Oral Biology, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0W4.
Naveena Yanamala
Jasbir Upadhyaya
Andrew Halayko
Judith Klein-Seetharaman
Prashen Chelikani
University of Manitoba · CAUniversity of Pittsburgh · US

Funding

Bridging Sequence Patterns and Structural DynamicsR01LM007994 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAHAR, IVET · 2004 to 2011
$3.0M
Canadian Institutes of Health Research ROP 92389NLM NIH HHS 2R01LM007994-05
6 · The paper itself

Abstract

G-protein coupled receptors (GPCRs) are transmembrane signaling molecules, with a majority of them performing important physiological roles. beta(2)-Adrenergic receptor (beta(2)-AR) is a well-studied GPCRs that mediates natural responses to the hormones adrenaline and noradrenaline. Analysis of the ligand-binding region of beta(2)-AR using the recently solved high-resolution crystal structures revealed a number of highly conserved amino acids that might be involved in ligand binding. However, detailed structure-function studies on some of these residues have not been performed, and their role in ligand binding remains to be elucidated. In this study, we have investigated the structural and functional role of a highly conserved residue valine 114, in hamster beta(2)-AR by site-directed mutagenesis. We replaced V114 in hamster beta(2)-AR with a number of amino acid residues carrying different functional groups. In addition to the complementary substitutions V114I and V114L, the V114C and V114E mutants also showed significant ligand binding and agonist dependent G-protein activation. However, the V114G, V114T, V114S, and V114W mutants failed to bind ligand in a specific manner. Molecular modeling studies were conducted to interpret these results in structural terms. We propose that the replacement of V114 influences not only the interaction of the ethanolamine side-chains but also the aryl-ring of the ligands tested. Results from this study show that the size and orientation of the hydrophobic residue at position V114 in beta(2)-AR affect binding of both agonists and antagonists, but it does not influence the receptor expression or folding.

Indexed as

Adenylyl CyclasesAdrenergic beta-AntagonistsAlprenololAnimalsBinding SitesChlorocebus aethiopsCOS CellsCricetinaeCyclic AMPModels, MolecularMutagenesis, Site-DirectedProtein BindingReceptors, Adrenergic, beta-2ValineAdenylyl CyclasesAdrenergic beta-AntagonistsAlprenololCyclic AMPReceptors, Adrenergic, beta-2Valine

Identifiers

PMID19916165
PMCPMC2817842
OpenAlexW1995781028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.